Ion channels and channelopathies in glomeruli

A Staruschenko, R Ma, O Palygin… - Physiological …, 2023 - journals.physiology.org
An essential step in renal function entails the formation of an ultrafiltrate that is delivered to
the renal tubules for subsequent processing. This process, known as glomerular filtration, is …

KDIGO 2021 clinical practice guideline for the management of glomerular diseases

BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

Collapsing focal segmental glomerulosclerosis in viral infections

AK Muehlig, S Gies, TB Huber, F Braun - Frontiers in Immunology, 2022 - frontiersin.org
Collapsing glomerulopathy represents a special variant of the proteinuric kidney disease
focal segmental glomerulosclerosis (FSGS). Histologically, the collapsing form of FSGS …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Recurrent glomerular disease after kidney transplantation: diagnostic and management dilemmas

A Uffing, F Hullekes, LV Riella… - Clinical Journal of the …, 2021 - journals.lww.com
Recurrent glomerular disease after kidney transplant remains an important cause of allograft
failure. Many of the different entities post-transplant still suffer from incomplete knowledge on …

Research priorities for therapeutic plasma exchange in critically ill patients

S David, L Russell, P Castro, A van de Louw… - Intensive Care Medicine …, 2023 - Springer
Therapeutic plasma exchange (TPE) is a therapeutic intervention that separates plasma
from blood cells to remove pathological factors or to replenish deficient factors. The use of …

Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome

H Trachtman, J Laskowski, C Lee… - American Journal …, 2021 - journals.physiology.org
Focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) are
common forms of idiopathic nephrotic syndrome. The causes of these diseases are …

[HTML][HTML] Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis

G Salfi, F Casiraghi, G Remuzzi - Frontiers in immunology, 2023 - frontiersin.org
The pathogenetic mechanisms underlying the onset and the post-transplant recurrence of
primary focal segmental glomerulosclerosis (FSGS) are complex and remain yet to be fully …

Consensus guidelines on management of steroid resistant nephrotic syndrome

A Vasudevan, R Thergaonkar, M Mantan… - Asian Journal of …, 2021 - journals.lww.com
Objective: To frame revised guidelines on diagnosis and evaluation, treatment and follow-
up, and supportive care of patients with the illness. Process: The guidelines combine …

[HTML][HTML] Efficacy of rituximab in treatment-resistant focal segmental glomerulosclerosis with elevated soluble urokinase-type plasminogen activator receptor and …

MA Hladunewich, D Cattran, SM Sethi… - Kidney international …, 2022 - Elsevier
Introduction Severe, nonresponsive, primary focal segmental glomerular sclerosis (FSGS)
can progress to end-stage kidney disease (ESKD) in< 5 years. Soluble urokinase-type …